| Mr Kyle P Noorlander, CRNA | |
|
1055 N Curtis Rd, Boise, ID 83706-1309 | |
| (208) 367-2559 | |
| Not Available |
| Full Name | Mr Kyle P Noorlander |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 5 Years |
| Location | 1055 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023672318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 83133 (Nebraska) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 61748 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic Llc | 1052217478 | 297 |
News Archive
Australian researchers are blaming land clearing and deforestation for the potential increase in mosquito-borne diseases.
In a column for Kaiser Health News, Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, writes the following: "Skilled health provider. Sympathetic caregiver. Trusted dispenser of medicines. Capable interpreter of complicated medical instructions.
InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.
Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.
› Verified 7 days ago
| Entity Name | Boise Anesthesia, P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487602298 PECOS PAC ID: 8426960642 Enrollment ID: O20031105000132 |
News Archive
Australian researchers are blaming land clearing and deforestation for the potential increase in mosquito-borne diseases.
In a column for Kaiser Health News, Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, writes the following: "Skilled health provider. Sympathetic caregiver. Trusted dispenser of medicines. Capable interpreter of complicated medical instructions.
InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.
Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.
› Verified 7 days ago
| Entity Name | St Lukes Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790718229 PECOS PAC ID: 1052217478 Enrollment ID: O20031208000899 |
News Archive
Australian researchers are blaming land clearing and deforestation for the potential increase in mosquito-borne diseases.
In a column for Kaiser Health News, Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, writes the following: "Skilled health provider. Sympathetic caregiver. Trusted dispenser of medicines. Capable interpreter of complicated medical instructions.
InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.
Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kyle P Noorlander, CRNA 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-6416 | Mr Kyle P Noorlander, CRNA 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-2559 |
News Archive
Australian researchers are blaming land clearing and deforestation for the potential increase in mosquito-borne diseases.
In a column for Kaiser Health News, Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, writes the following: "Skilled health provider. Sympathetic caregiver. Trusted dispenser of medicines. Capable interpreter of complicated medical instructions.
InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.
Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.
› Verified 7 days ago
Mr. Douglas Neurath, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 | |
Jordan B Wolff, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 Fax: 208-338-1796 | |
Nathan S Call, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Ashton Mieritz, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 | |
Kenneth Clark Stratton Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2559 | |
Diana San Juan Shimko, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-6416 | |
David Hansen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 338 E Bannock St, Boise, ID 83712 Phone: 208-336-0895 |